Levator ani transcriptomic signature

Levator ani transcriptomic signature is associated with overall clinical phenotype profile in humans (ρ=0.88; false discovery rate <0.05).

“The correlation between the transcriptomic signature (principal component 3) and the overall clinical phenotype profile (principal component 1) was significant (ρ=0.88, false discovery rate <0.05)”

HumansPostpartum after first vaginal delivery; transcriptomic principal component 3 versus clinical principal component 1levator ani musclefemalesn = 8

Transcriptomic evidence of remodeling in postpartum levator ani muscle associated with maternal age and recovery time after first vaginal delivery

American journal of obstetrics and gynecology·15 Apr 2026